DEF 14A

Company

CytoDyn Inc.

Filed

July 24, 2017

Period of Report

August 24, 2017

Accession Number

0000950123-17-006255

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →